Faculty profile

Kaarina Kowalec

ResearcherCollege of PharmacyUniversity of Manitoba

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Manitoba directory, so their courses may be missing. Find their university profile.

Kaarina Kowalec

Researcher

College of Pharmacy

Health Sciences

University of Manitoba

Winnipeg, Manitoba, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
47 publications in the last five years, latest in 2026.
Senior (last) author on 6 recent papers, a sign of leading a research group.
Principal investigator on 1 research grant (1 CIHR), most recently in 2025.
Supervised 1 trainee who won CIHR awards, most recently in 2025.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Functional Validation Genetic Epidemiology Genetics Manitoba Pharmacogenetics Rare Variants Register Genomics Regulatory Function

Latest papers

A Genome-Wide Association Study of Premenstrual Symptoms in Two Nordic Populations.
Biological psychiatry global open science · 2026
Assessing the feasibility, theoretical interest, and observed behaviors of adding genetic data to a patient-reported multiple sclerosis registry.
Multiple sclerosis journal - experimental, translational and clinical · 2026 · first author
Lymphocyte count polygenicity underlies dimethyl fumarate-associated lymphopenia in multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England) · 2026 · first author

All 58 publications

Latest funding

Uncovering Schizophrenia Genetics through Whole Genome Sequencing across Manitoba and Sweden.
CIHR · 2025 · Nominated PI
$1,143,675
Resilience in schizophrenia: A comprehensive study of genetic risk, clinical trajectories, and psychosocial factors across illness phases
CIHR · 2025 · Supervisor
$120,000
Examining intersections of biographies & biologies: diversity & outcomes of people with multiple sclerosis in Canada (iBio2Div-MS)
CIHR · 2024 · Co-investigator
$19,955

All 3 grants and awards

58 publications.

A Genome-Wide Association Study of Premenstrual Symptoms in Two Nordic Populations.

Hysaj E, Jaholkowski P, Shadrin AA, Bergstedt J, Lu Y, Bertone-Johnson E, Bulik CM, Landén M, Sandin S, Kowalec K, Hägg S, Di Florio A, Goldman D, Schmidt PJ, Valdimarsdóttir UA, Andreassen OA, Lu D

Biological psychiatry global open science2026

DOI: 10.1016/j.bpsgos.2026.100784 PMID: 42633314

Assessing the feasibility, theoretical interest, and observed behaviors of adding genetic data to a patient-reported multiple sclerosis registry.

Kowalec K, Menendez D, Cutter G, Fox RJ, Marrie RA, Salter A

Multiple sclerosis journal - experimental, translational and clinical2026First author

DOI: 10.1177/20552173261467203 PMID: 42633005

Lymphocyte count polygenicity underlies dimethyl fumarate-associated lymphopenia in multiple sclerosis.

Kowalec K, Manouchehrinia A, Kingwell E, Carruthers R, Marrie RA, Evans C, Rotstein D, Kuan AJ, Luo W, Luo D, Desrochers B, Jokubaitis VG, Lechner-Scott J, Maltby VE, Groen K, Wright GE, Drögemöller BI, Bernatsky S, Levin MC, Knox K, Maruf AA, Zhong M, Alfredsson L, Hillert J, Kockum I, Olsson T, Stridh P, Shchetynsky K, Dever K, MacIsaac J, Kobor MS, Tremlett H

Multiple sclerosis (Houndmills, Basingstoke, England)2026First author

DOI: 10.1177/13524585261471335 PMID: 42608789

The association of schizophrenia polygenic scores with continuously-hospitalized, treatment-resistant schizophrenia.

Das U, Crowley JJ, Karlsson R, Lu Y, O'Donovan M, Walters JTR, Didriksen M, Josiassen R, Sullivan PF, Kowalec K

Molecular psychiatry2026Senior author

DOI: 10.1038/s41380-026-03806-x PMID: 42552419

Sex differences in the rate and factors for elevated depressive symptoms in multiple sclerosis, inflammatory bowel disease, and rheumatoid arthritis.

Riel H, Jacobo FL, Bernstein CN, Bolton JM, Fisk JD, Graff LA, Hitchon C, Mayo C, Patten SB, Marrie RA, Kowalec K, CIHR Team in Defining the Burden and Managing the Effects of Psychiatric Comorbidity in Chronic Immunoinflammatory Disease

Journal of health psychology2026Senior author

DOI: 10.1177/13591053251396478 PMID: 41545017

Early Discontinuation of Antidepressants in Mood and Anxiety Disorders: A Narrative Review of Factors and Strategies to Improve Adherence.

Aziz MA, Maruf AA, Bolton JM, Kowalec K, Eltonsy S, Leong C

Journal of clinical psychopharmacology2026

DOI: 10.1097/jcp.0000000000002217 PMID: 42479561

Disruptions in perinatal outcomes across Manitoba, Canada: before and over 2 years of the COVID-19 pandemic.

Aboulatta L, Kowalec K, Lix LM, Tadrous M, Delaney JA, Leong C, Falk J, Alessi-Severini S, Raimondi C, Kearns K, Haidar L, Peymani P, Tan Q, Eltonsy S

BMJ paediatrics open2026

DOI: 10.1136/bmjpo-2026-004616 PMID: 42373196

A scoping review of genetic studies of treatment-resistant schizophrenia.

Das U, Riel H, Enriquez MR, Shirinbakhshmasoleh M, Rose A, Herrera M, Lu Y, Kowalec K

Frontiers in genetics2026Senior author

DOI: 10.3389/fgene.2026.1802472 PMID: 42238819

Genome-wide association analyses identify distinct genetic architectures for early-onset and late-onset depression.

Shorter JR, Pasman JA, Kurvits S, Jangmo A, Naamanka J, Harder A, Hagen E, Kowalec K, Frilander N, Zetterberg R, Meijsen JJ, Gådin JR, Bergstedt J, Xiong Y, Hägg S, Landén M, Rück C, Wallert J, Skalkidou A, Koch E, Akdeniz BC, Frei O, FinnGen, Hovatta I, Reichborn-Kjennerud T, Werge TM, Sullivan PF, Andreassen OA, Tesli M, Lehto K, Buil A, Lu Y

Nature genetics2025

DOI: 10.1038/s41588-025-02396-8 PMID: 41233554

Depression Polygenicity and Disease Activity and Disability Worsening in Multiple Sclerosis.

Manouchehrinia A, Fitzgerald KC, Salter A, Marrie RA, Alfredsson L, Bernstein CN, Bolton JM, Cutter G, Fisk JD, Graff LA, Hitchon CA, Hillert J, Kockum I, Lu Y, Lublin FD, McKay K, Olsson T, Patten S, Patki A, Riel H, Shchetynsky K, Stridh P, Tiwari HK, Wolinsky JS, Kowalec K

Annals of neurology2025Senior author

DOI: 10.1002/ana.70020 PMID: 40772555

Something wrong or missing on this profile? Suggest a correction

Kaarina Kowalec

Research

Latest papers

Latest funding

A Genome-Wide Association Study of Premenstrual Symptoms in Two Nordic Populations.

Assessing the feasibility, theoretical interest, and observed behaviors of adding genetic data to a patient-reported multiple sclerosis registry.

Lymphocyte count polygenicity underlies dimethyl fumarate-associated lymphopenia in multiple sclerosis.

The association of schizophrenia polygenic scores with continuously-hospitalized, treatment-resistant schizophrenia.

Sex differences in the rate and factors for elevated depressive symptoms in multiple sclerosis, inflammatory bowel disease, and rheumatoid arthritis.

Early Discontinuation of Antidepressants in Mood and Anxiety Disorders: A Narrative Review of Factors and Strategies to Improve Adherence.

Disruptions in perinatal outcomes across Manitoba, Canada: before and over 2 years of the COVID-19 pandemic.

A scoping review of genetic studies of treatment-resistant schizophrenia.

Genome-wide association analyses identify distinct genetic architectures for early-onset and late-onset depression.

Depression Polygenicity and Disease Activity and Disability Worsening in Multiple Sclerosis.

Uncovering Schizophrenia Genetics through Whole Genome Sequencing across Manitoba and Sweden.

Resilience in schizophrenia: A comprehensive study of genetic risk, clinical trajectories, and psychosocial factors across illness phases

Examining intersections of biographies & biologies: diversity & outcomes of people with multiple sclerosis in Canada (iBio2Div-MS)

Frequent collaborators

Sherif Eltonsy

Carol Hitchon

Jitender Sareen

Scott Patten

Helen Tremlett

Yi Lu

Sarvesh Logsetty

Katherine Kearns

Christina Raimondi

Charity Evans

Marcus Ng

Souradet Shaw

Rae Spiwak

Chad Bousman

Kaarina Kowalec

Sasha Bernatsky

Colleen Maxwell

James Bolton

Anick Bérard

Sasha Bernatsky

Anick Bérard